Radiopharm Theranostics RDPTF Growth Metrics (2024-2026)

NASDAQ RDPTF
$0.01 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

Radiopharm Theranostics Quarterly Growth Metrics

Periods 3 quarters
Latest Jun 2026

Radiopharm Theranostics reported revenue growth of 257.81% and asset growth of -22.98% for the quarter ended Jun 2026. These growth metrics cover 3 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Jun2024 Jun2025 Jun2026
Growth Ratios
Assets Growth (1y) 16.67%-22.98%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) -98.95%52.33%-84.26%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) -86.41%
EBITDA Margin Growth (1y) -5.62M5.61M
EBIT Growth (1y) 99.24%-14,396.10%98.14%
EBIT Growth (3y) 72.58%
EBIT Margin Growth (1y) -5.62M5.61M
EBT Growth (1y) -38.41%20.09%98.14%
EBT Growth (3y) 72.60%
EBT Margin Growth (1y) -3.62M5.62M
EPS (Basic) Growth (1y) 99.40%-2,589.30%98.13%
EPS (Basic) Growth (3y) 85.53%
EPS (Diluted) Growth (1y) 99.40%-2,589.30%98.13%
EPS (Diluted) Growth (3y) 85.53%
Gross Margin Growth (1y) -0.52M0.52M
Gross Profit Growth (1y) -15,121.92%97.37%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) -99.90%142,616.17%
Net Income Growth (1y) 99.24%-14,381.67%98.13%
Net Income Growth (3y) 72.59%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) 99.24%-14,381.67%98.13%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y) 72.59%
Net Margin Growth (1y) -5.62M5.60M
Operating Income Growth (1y)Op. Inc Growth (1y) -36.89%19.14%98.14%
Operating Income Growth (3y)Op. Inc Growth (3y) 72.58%
Operating Margin Growth (1y) -3.64M5.61M
Profit After Tax Growth (1y)PAT Growth (1y) -35.11%20.67%98.12%
Profit After Tax Growth (3y)PAT Growth (3y) 72.80%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -5.20%
Return on Sales [ROS] Growth (1y)ROS Growth (1y) -5.62M5.61M
Revenue Growth (1y) -71.39%257.81%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 13.09%28.21%
Tax Rate Growth (1y) 9.007.00
Total Debt Growth (1y) -6.68%-11.06%